{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:34:52Z","timestamp":1787668492280,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.fertnstert.2021.08.032","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T04:07:13Z","timestamp":1634270833000},"page":"160-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Infiltrating T lymphocytes and programmed cell death protein-1\/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4442-4046","authenticated-orcid":false,"given":"Camilla","family":"Nero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Romito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saveria","family":"Spadola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Romito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Carlo","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Ninno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Catena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"De Cicco Nardone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Zannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2021.08.032_bib1","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","article-title":"Clinical practice. Endometriosis","volume":"362","author":"Giudice","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib2","doi-asserted-by":"crossref","first-page":"107.e1","DOI":"10.1016\/j.ajog.2020.01.041","article-title":"Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study","volume":"223","author":"Hermens","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00404-020-05445-1","article-title":"Association between endometriosis and gynecological cancers: a critical review of the literature","volume":"301","author":"Kalaitzopoulos","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.fertnstert.2015.09.023","article-title":"Evidence of a genetic link between endometriosis and ovarian cancer","volume":"105","author":"Lee","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib6","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1093\/humrep\/det340","article-title":"Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis","volume":"28","author":"Buis","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2014.1002732","article-title":"Chronic inflammation in endometriosis and endometriosis-associated ovarian cancer: new roles for the \u201cold\u201d complement pathway","volume":"4","author":"Edwards","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/07357907.2012.681821","article-title":"Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalities","volume":"30","author":"Shigetomi","year":"2012","journal-title":"Cancer Invest"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10147-009-0935-y","article-title":"Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management","volume":"14","author":"Mandai","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2559.1997.d01-592.x","article-title":"Ovarian atypical endometriosis: its close association with malignant epithelial tumours","volume":"30","author":"Fukunaga","year":"1997","journal-title":"Histopathology"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/rep.1.00020","article-title":"Endometriosis and the neoplastic process","volume":"127","author":"Varma","year":"2004","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib12","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1158\/1078-0432.CCR-14-1338","article-title":"Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer","volume":"20","author":"Suryawanshi","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib13","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1002\/cam4.1741","article-title":"Role of tumor microenvironment in the pathobiology of ovarian cancer: insights and therapeutic opportunities","volume":"7","author":"Ghoneum","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fimmu.2016.00550","article-title":"The PD1:PD-L1\/2 pathway from discovery to clinical implementation","volume":"7","author":"Bardhan","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib15","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9","article-title":"PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2","volume":"32","author":"Carter","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib17","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1158\/1078-0432.CCR-07-4433","article-title":"HLA class I antigen processing machinery component expression and intratumoral T-cell infiltrate as independent prognostic markers in ovarian carcinoma","volume":"14","author":"Han","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archsurg.1925.01120100007001","article-title":"Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ","volume":"10","author":"Sampson","year":"1925","journal-title":"Arch Surg"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib19","first-page":"283","article-title":"Malignant changes in endometriosis","volume":"2","author":"Scott","year":"1953","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","article-title":"2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer","volume":"133","author":"Mutch","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib21","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00404-016-4142-6","article-title":"Characterization of endometriosis-associated immune cell infiltrates (EMaICI)","volume":"294","author":"Scheerer","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib26","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1158\/0008-5472.CAN-14-0157","article-title":"Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche","volume":"74","author":"Vadrevu","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1158\/0008-5472.CAN-17-0240","article-title":"Complement activation via a C3a receptor pathway alters CD4+ T lymphocytes and mediates lung cancer progression","volume":"78","author":"Kwak","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1349587","article-title":"Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1\/PD-L1 blockade","volume":"6","author":"Zha","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1186\/s12885-017-3585-x","article-title":"Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer","volume":"17","author":"James","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.immuni.2016.07.011","article-title":"Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis","volume":"45","author":"Schietinger","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib31","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.cell.2018.03.073","article-title":"Interfaces of malignant and immunologic clonal dynamics in ovarian cancer","volume":"173","author":"Zhang","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib32","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1158\/0008-5472.CAN-08-3804","article-title":"FOXP3 defines regulatory T cells in human tumor and autoimmune disease","volume":"69","author":"Kryczek","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/09513590.2018.1519787","article-title":"Expression of programmed death-1 (PD-1) and its ligand PD-L1 is upregulated in endometriosis and promoted by 17beta-estradiol","volume":"35","author":"Wu","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7041342","article-title":"The increase of circulating PD-1- and PD-L1- expressing lymphocytes in endometriosis: correlation with clinical and laboratory parameters","volume":"2018","author":"Walankiewicz","year":"2018","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib35","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/13547500903183970","article-title":"Cytokine array analysis of peritoneal fluid between women with endometriosis of different stages and those without endometriosis","volume":"14","author":"Hou","year":"2009","journal-title":"Biomarkers"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib36","first-page":"527","article-title":"Serum and peritoneal abnormalities in endometriosis: potential use as diagnostic markers","volume":"58","author":"Gupta","year":"2006","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bpobgyn.2018.01.010","article-title":"Immunology of endometriosis","volume":"50","author":"Riccio","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib38","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.molmed.2018.07.004","article-title":"The immunopathophysiology of endometriosis","volume":"24","author":"Symons","year":"2018","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/humrep\/det401","article-title":"Can chemokines be used as biomarkers for endometriosis? A systematic review","volume":"29","author":"Borrelli","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/aji.12206","article-title":"Expression of natural cytotoxicity receptors on peritoneal fluid natural killer cell and cytokine production by peritoneal fluid natural killer cell in women with endometriosis","volume":"71","author":"Funamizu","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2021.08.032_bib41","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.fertnstert.2013.01.133","article-title":"Possible involvement of signal transducer and activator of transcription-3 in cell-cell interactions of peritoneal macrophages and endometrial stromal cells in human endometriosis","volume":"99","author":"Itoh","year":"2013","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221019737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221019737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T16:31:52Z","timestamp":1748449912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028221019737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0015028221019737"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.08.032","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infiltrating T lymphocytes and programmed cell death protein-1\/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92021 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}